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Abstract
Background: Doublecortin (Dcx), a MAP (Microtubule-Associated Protein), is transiently expressed in migrating and 
differentiating neurons and thereby characterizes neuronal precursors and neurogenesis in developing and adult 
neurogenesis. In addition, reduced Dcx expression during development has been related to appearance of brain 
pathologies. Here, we attempt to unveil the molecular mechanisms controlling Dcx gene expression by studying its 
transcriptional regulation during neuronal differentiation.
Results: To determine and analyze important regulatory sequences of the Dcx promoter, we studied a putative 
regulatory region upstream from the mouse Dcx coding region (pdcx2kb) and several deletions thereof. These different 
fragments were used in vitro and in vivo to drive reporter gene expression. We demonstrated, using transient 
expression experiments, that pdcx2kb is sufficient to control specific reporter gene expression in cerebellar cells and in 
the developing brain (E14.5). We determined the temporal profile of Dcx promoter activity during neuronal 
differentiation of mouse embryonic stem cells (mESC) and found that transcriptional activation of the Dcx gene varies 
along with neuronal differentiation of mESC. Deletion experiments and sequence comparison of Dcx promoters across 
rodents, human and chicken revealed the importance of a highly conserved sequence in the proximal region of the 
promoter required for specific and strong expression in neuronal precursors and young neuronal cells. Further analyses 
revealed the presence in this short sequence of several conserved, putative transcription factor binding sites: LEF/TCF 
(Lymphoid Enhancer Factor/T-Cell Factor) which are effectors of the canonical Wnt pathway; HNF6/OC2 (Hepatocyte 
Nuclear Factor-6/Oncecut-2) members of the ONECUT family and NF-Y/CAAT (Nuclear Factor-Y).
Conclusions: Studies of Dcx gene regulatory sequences using native, deleted and mutated constructs suggest that 
fragments located upstream of the Dcx coding sequence are sufficient to induce specific Dcx expression in vitro: in 
heterogeneous differentiated neurons from mESC, in primary mouse cerebellar neurons (PND3) and in organotypic 
slice cultures. Furthermore, a region in the 3'-end region of the Dcx promoter is highly conserved across several species 
and exerts positive control on Dcx transcriptional activation. Together, these results indicate that the proximal 3'-end 
region of the mouse Dcx regulatory sequence is essential for Dcx gene expression during differentiation of neuronal 
precursors.
Background
The DCX gene is located on the X chromosome (Xq22.3-
q23) and encodes a 40 kDa phosphoprotein of 360 amino
acids. The DCX protein is a microtubule-associated pro-
tein (MAP) that interacts with and stabilizes the microtu-
b u l e  c y t o s k e l e t o n  [ 1 , 2 ] .  T h i s  g e n e  i s  s p e c i f i c a l l y  a n d
transiently expressed in proliferating neuronal progeni-
tors and in post-mitotic neuronal precursors during
embryonic development and in neurogenic regions of the
adult brain [2-5]. DCX expression occurs during cortico-
genesis and is absent during regenerative axonal growth,
suggesting that DCX is a selective marker of cells com-
mitted to the neuronal lineage in both developing and
adult brain [6,7]. One or more mutations in the DCX gene
cause X-Linked Subcortical Laminar Band Heterotopia
(X-SCLH)/Lissencephaly (LIS) [2,8]. This developmental
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brain malformation syndrome is caused by abnormal
neuronal migration leading to a profound cerebral corti-
cal layer disorganization resulting in mental retardation
and epilepsy.
Such alterations in cortical lamination observed in
humans were not detected in mice with Dcx gene dele-
tion; lamination defects were only observed in the hip-
pocampus [9]. In contrast, RNA interference (RNAi)-
mediated knock-down of Dcx in rodents caused impair-
ment in radial migration of cortical neurons [10,11]. Sim-
ilarly, mice with mutations of both Dcx  and  Dclk
(Doublecortin-like kinase gene, homolog of the Dcx gene)
genes presented both disorganized neocortical lamina-
tion and severe cytoarchitectural defects of the hip-
pocampus, suggesting redundant functions of Dcx and
Dclk during neuronal migration [12-14].
Neuronal differentiation is a tightly orchestrated time-
and location-dependent process in which many extracel-
lular and intrinsic factors are involved [15-17]. Whereas
the temporal and spatial Dcx expression patterns and Dcx
post-translational regulations are well known, Dcx tran-
scriptional regulation is poorly understood. However, to
understand the mechanisms involved in neuronal differ-
entiation during embryogenesis and more precisely in
stages before neuronal determination, it is crucial to
investigate the transcriptional gene control in action dur-
ing neuronal differentiation. In view of the relevance of
Dcx as a marker for neurogenesis and considering the
importance of understanding Dcx  gene regulation, we
analyzed a putative regulatory region upstream of the
mouse Dcx gene (pdcx2kb) and used it to drive reporter
gene expression. We characterized the Dcx  promoter
activity at different time-points during neuronal differen-
tiation of mESC (mouse embryonic stem cells) and we
defined a small region as an element required to provide
specific and strong expression in neuronal precursors and
young neuronal cells.
Results
To study transcriptional regulation of the mouse dou-
blecortin  gene (Accession number NT_039718), we
selected a 2kb-long fragment upstream of the transcrip-
tion initiation site of the longest reported Dcx mRNA
transcript (Accession number NM_001110222). This
2kb-long fragment (pdcx2kb) contained TATA and
CAAT boxes and was cloned into promoterless reporter
(eGFP or Luciferase) vectors for analysis (Figure 1a).
Cell type-specific activity of the 2kb-long Dcx promoter 
fragment
We first wanted to determine whether pdcx2kb was suffi-
cient to induce transcriptional activity and to drive it spe-
cifically in cells expressing the endogenous Dcx  gene,
namely neuronal precursor cells. Two mouse cell types
were used: cerebellar neurons from post-natal day 3 mice
(PND3) in which endogenous Dcx expression has already
been reported [18] and mouse embryonic stem (ESR1)
cells.
Cell specificity of pdcx2kb transcriptional activity was
observed in both heterogeneous cell cultures by transient
expression of the eGFP protein upon transfection with
pdcx2kb-eGFP constructs (Figure 1b). In primary cere-
bellar cells, eGFP under the control of pdcx2kb was
detected only in cells expressing the endogenous Dcx
gene and not in other cell types, such as GFAP-expressing
astrocytes (Figure 1b: A-H). Control experiments using
the widely active pCMV-eGFP construct revealed that
eGFP fluorescence was detected indifferently in all cell
types, neurons and glial cells alike. Both GFAP- and Dcx-
positive cells were fluorescent (Figure 1b: I-P), showing
that the transfection process was not cell-specific. Simi-
larly, eGFP expression was only detected in ESR1 cells
after neuronal differentiation and was limited to Dcx-
positive or βIII-Tubulin-positive cells, confirming
pdcx2kb selectivity to Dcx-positive neuronal precursor
cells in vitro (data not shown).
Ex vivo electroporation of embryonic mouse brains was
also conducted to confirm cell selectivity of pdcx2kb
activity in a more physiological setting. pdcx2kb-eGFP
was transfected in brains of E14.5-E15.5 mice, a specific
time point of corticogenesis [19]. Dcx expression was
observed in migrating cortical neurons originating from
progenitor cells located near the ventricular proliferative
zone. Following pdcx2kb-eGFP transfection, fluorescence
was observed around the electroporation site in the pro-
liferative zone of the cerebral cortex. Fluorescent cells
displayed morphology similar to that of migrating neu-
ronal precursors (Figure 1c). Moreover, all fluorescent
cells also expressed Dcx. Taken together, these qualitative
analyses show that the 2kb-long fragment upstream of
the Dcx gene possesses regulatory sequences sufficient to
mimic the activity of the endogenous Dcx gene in mouse
embryos and to limit its activity to Dcx-positive neuronal
precursors.
Transcriptional activity of the Dcx promoter in 
differentiating ES cells
To study more efficiently the transcriptional regulation of
the mouse Dcx gene, we chose to use mouse embryonic
stem (ESR1) cells: these cells are able to proliferate indefi-
nitely in vitro while retaining pluripotency, and also to
differentiate into a large variety of cell types in vitro.
Hence, mouse ES cells can differentiate into neural pre-
cursors able to generate functional neurons [20], astro-
cytes and oligodendrocytes [21,22]. Using our protocol
(see Material and Methods), induction of neuronal differ-
entiation leads to a progressive change in ESR1 cell mor-
phology to a characteristic cobblestone structure and, byPiens et al. BMC Neuroscience 2010, 11:64
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neuronal differentiation day 8 (DD8), ESR1 cells begin to
form long cellular processes. From DD8/10 on, bipolar
cells proliferate and form rosettes.
Dcx protein was detected at DD6 of ESR1 differentia-
tion (Figure 2) and was still present in immature neuronal
cells-derived from ESR1 cells at DD8 and DD18. Based on
these observations and on the detection of Dcx mRNA at
DD4, we decided to use ESR1 at DD6 for further analysis
of the transcriptional activity of the mouse Dcx promoter.
To characterize relevant regions of pdcx, we dissected
the 2kb-long fragment into shorter fragments of 1.2 kb, 1
kb (obtained by PCR) and 249 bp (obtained by enzymatic
restriction), and inserted them upstream of the luciferase
reporter gene.
Comparison of the respective activities of all constructs
(Figure 3a) in ESR1 cells at DD8 revealed a higher activity
in cells transfected with pdcx2kb than in control cells (fig-
ure 3b). Transcriptional activities were also higher in cells
transfected with shorter fragments (pdcx1kb and
pdcx249bp) than with pdcx2kb (Figure 3b). In contrast,
the 1.2kb-long pdcx fragment did not induce a transcrip-
tional activity different from control, suggesting the pres-
Figure 2 Confirmation of Dcx expression in cerebellum extracts 
and embryonic stem cells during neuronal differentiation. ESR1 
cells were subjected to detergent extraction as described in Materials 
and Methods at day of differentiation 0 (DD0), DD4, DD6, DD8 (on gel-
atin) and DD10 (on poly-ornithine/laminin). 20 μg of total protein were 
separated on 10% SDS-PAGE gels, immunoblotted and reacted with 
the corresponding antibodies; (upper panel) anti-Doublecortin and 
(lower panel) anti-α-Tubulin.
Figure 1 Neuronal lineage specificity of the doublecortin regulatory sequence (pdcx2kb-eGFP). (a) Schematic representation of the mouse 
Dcx promoter construct for reporter gene expression: black boxes (E1 and E2) represent the first two exons of the Dcx gene: the localization of putative 
CAAT/TATA boxes and ATG start codon are shown (b) Cerebellar Granule neurons (CGN) extracted from PND3 mice were transiently transfected with 
pdcx2kb-eGFP (A-H) or pCMV-eGFP (I-P). After 72 hrs, expression of eGFP was analyzed using an inverted fluorescence microscope and compared with 
the neuronal cell-specific marker Dcx or astroglial cell-specific marker GFAP; DAPI was used as a nuclear counterstain. In cells transfected with the 
pdcx2kb plasmid, co-expression was observed between eGFP and Dcx (A-D). No expression overlap is observed between eGFP and GFAP (E-H). Cells 
transfected with pCMV-eGFP plasmid (I-P) present a strong eGFP expression with Dcx (I-L) and with GFAP (M-P). Scale bar equals 50 μm. (c) E15 em-
bryonic mouse brains were electroporated with pdcx2kb-EGFP plasmid. After 4 days, organotypic slices were sectioned, immunostained with Dcx and 
counterstained with DAPI. Slices were analyzed by confocal microscopy. The insert shows the location of the microphotograph: eGFP, Dcx and their 
co-localization are presented. Scale bar equals 50 μm.Piens et al. BMC Neuroscience 2010, 11:64
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ence of a transcriptional repressor region in this 200 bp
fragment. In addition, deletion of 79 bp at the 3'end of
pdcx1kb (pdcx1kb-) prevented the pdcx1kb-induced
increase of activity. This last result suggested the pres-
ence of important regulatory domains at the 3'end of
pdcx, especially in a 79bp-long fragment. Similar effects
on the transcriptional activities of the different con-
structs were observed in PND3 cerebellar cells (Figure
3c), confirming the presence of similar regulatory control
mechanisms in neuronal precursors from both origins
(ESR1 cells and primary cerebellar cells). However, a dis-
crepancy is observed between the relative activity of
pdcx1kb and pdcx249bp between both cell cultures (Fig-
ure 3b and 3c), maybe reflecting the fact that the target
regulatory elements necessary for the Dcx gene expres-
sion are different in two cell types. Indeed, it is quite pos-
sible that activators or inhibitor elements, located in
pdcx1kb and pdcx249bp respectively, are most needed
during the differentiation of CGN compared to neuro-
b l a s t s  f r o m  E S C .  A t  t h a t  s t a g e  ( D D 6 ) ,  E S R 1  c e l l s  a r e
plated on gelatin-coated plates while cerebellar cells are
plated on poly-ornithine substrate (necessary for cell
adhesion) (see also below).
The same relative activities of the promoter fragments
were maintained throughout the entire differentiation
program in ESR1 cells (Figure 4). Indeed, when ESR1 cells
were transfected every second day throughout the entire
differentiation period and the luciferase activity mea-
sured 48 hours later, increasing levels of activities were
observed along the process with a peak at the transfer
Figure 3 Transcriptional activity of the mouse Dcx upstream regulatory sequences in embryonic stem cells during neuronal differentiation 
and in cerebellar cells. (a) Schematic representation of the mouse Dcx promoter constructs for reporter gene expression. Cells were co-transfected 
with Dcx promoter constructs or the basic vector (promoterless luciferase vector; CTL) and control pSV-β-Galactosidase vector. Luciferase activity (ex-
pressed in RLU), of each transfection was determined after 48 hours and normalized to the corresponding internal control, β-Galactosidase activity 
(OD at 420 nm). (b) ESR1 cells were transfected at DD6 program and (c) CGN were extracted from PND3 mice and transfected the same day. Each 
value represents the mean ± SEM of at least three independent transfection experiments, each performed in triplicate. Asterisks mean significantly 
different from pdcx2kb values at P < 0.05 (*) or P < 0.01 (**).Piens et al. BMC Neuroscience 2010, 11:64
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onto poly-ornithine/lamin substrate for constructs
pdcx2kb, pdcx1kb and pdcx249bp. The time-course stud-
ies confirmed the inhibition or the significant reduction
of the transcriptional activity of pdcx at all stages by dele-
tion of 79b at the 3' end of the pdcx sequences in con-
structs  pdcx1kb and pdcx249bp (pdcx1kb-  and
pdcx249bp-, respectively). Finally, we also examined the
cellular specificity of pdcx1kb and pdcx249bp in differen-
t i a t e d  E S R 1  a n d  P N D 3  c e r e b e l l a r  c e l l s  a n d  c o n f i r m e d
that, similar to the pdcx2kb construct (Figure 1b), both
pdcx1kb and pdcx249bp fragments restricted the expres-
sion of the eGFP reporter gene in Dcx-expressing cells
(data not shown).
Transcription factors regulating the mouse Dcx promoter
Comparative analyses were performed on the sequences
of mouse, rat, human and chicken 2kb-long Dcx  pro-
moter fragments using the VISTA software (Figure 5). A
high sequence similarity was found between mouse and
rat pdcx2kb sequences. Comparison between mouse and
human sequences revealed that sequence conservation
was not detected throughout the 2kb-long sequence, but
was limited to a ± 500 bp portion located at the pdcx2kb
3'-end. Similarly, sequence conservation between the
mouse  pdcx2kb and the chicken pdcx2kb was only
observed in a 183bp-long fragment located at the 3'-end.
In addition, the strongest sequence conservation between
mouse, rat, human and chicken pdcx2kb sequences was
Figure 5 A 183 bp region is highly conserved between different 
amniotes species. Genomic sequences of mouse, rat, human and 
chick pdcx were compared using the VISTA http://www-gsd.lbl.gov/
VISTA/ software. The positions of the sequences are shown on the hor-
izontal axis and the percent identities (50-100%) are indicated in the 
vertical axis.
Figure 4 Transcriptional activity of the mouse Dcx upstream regulatory sequences in embryonic stem cells during differentiation. Every sec-
ond day, cells were co-transfected with the indicated Dcx promoter construct or the promoterless control (CTL). Normalized luciferase activity corre-
sponds to the luciferase activity (expressed in RLU) of each transfection (determined 48 hours later) normalized to the corresponding internal control, 
β-Galactosidase activity (expressed in OD at 420 nm) (see materials and methods). Each value represents mean ± SEM of at least three independent 
transfection experiments, each performed in triplicate.Piens et al. BMC Neuroscience 2010, 11:64
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detected within this 183bp-long fragment (Figure 5). Fur-
ther analysis, using the MatInspector software, revealed
that many putative binding sites for members of several
transcription factor families known to participate in neu-
ronal differentiation/migration such as NEUROD, NEU-
ROG, BRN, PAX, HOX, SOX and DLX are present in the
249bp-, 1kb-, 2kb-long Dcx promoter fragments (Addi-
tional file 1: Table S1). In particular, this analysis revealed
four conserved consensus binding sites for known tran-
scription factors in the 79b-long fragment located at the
3'end of the Dcx promoter (Figure 6): two perfect consen-
sus sites for NF-Y/CAAT, one perfect site for LEF/TCF
which are effectors of the canonical Wnt pathway and
one imperfect site for HNF6/OC2 (75% conserved rela-
tive to consensus), members of the ONECUT family [23-
25].
Expression of putative transcription factors during 
neuronal differentiation of mESC
To investigate which of these transcription factors, pres-
ent in the 79 bp fragment and potentially involved in Dcx
gene regulation, are expressed during neuronal differenti-
ation of ESR1 cells, the levels of mRNA coding for Dcx
and for each factor (Lef, Tcf1, Tcf3 and Tcf4, Hnf6 and
Oc2, Nf-ya, Nf-yb and Nf-yc) were measured at different
time-points during neuronal differentiation (Figure 7).
The abundance of each transcript at each stage was cal-
culated relative to the Gapdh housekeeping gene mRNA,
based on published results [26-28]. The observed pattern
of Dcx transcript expression is consistent with that of Dcx
protein synthesis during neuronal differentiation of ESR1
cells and with the observed transcriptional activity of the
Dcx  promoter (see above). No Dcx  transcript was
d e t e c t e d  i n  u n d i f f e r e n t i a t e d  E S R 1  c e l l s .  L e v e l s  o f  Dcx
Figure 6 Nucleotide sequence of the mouse Dcx gene regulatory sequence. The fragments corresponding to pdcx2kb, pdcx1.2kb, pdcx1kb (ob-
tained by PCR) and pdcx249bp (obtained by enzymatic restriction) are represented. Sequence of 79 bp Δ(-1820 -1741 from ATG of Dcx gene) is indi-
cated in bold and putative binding sites for transcription factors NF-Y, HNF6 and LEF/TCF surrounded by boxes. Reporter gene translation Initiation 
Site is highlighted in bolt.Piens et al. BMC Neuroscience 2010, 11:64
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Figure 7 Expression of transcription factors predicted to bind the Dcx regulatory sequence in the 3'-end region. The relative abundance of 
mRNA coding for Dcx, Lef, Tcf1, Tcf3, Tcf4, Hnf6, Oc2 and Nf-ya, Nf-yb and Nf-yc were determined by semi-quantitative PCR at DD0, DD4 and DD8 on 
gelatin and at day of differentiation DD8, DD18 and DD28 on poly-ornithine/laminin. Gapdh was used as internal control.Piens et al. BMC Neuroscience 2010, 11:64
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transcripts progressively increased to reach a maximum
at DD18 followed by a reduction at DD28. Each tran-
scription factor transcript was detected in ESR1 cells.
The temporal profile of Lef, Hnf6 and Tcf4 transcription
factors presented patterns of expression similar to that of
Dcx, suggesting that expression of these transcription fac-
tors is also dependent on neuronal differentiating time.
Their levels were relatively low during the early phase of
ESR1 cell differentiation (DD0-8), progressively increased
during the late phase of the differentiation program to
peak at DD18 when Dcx transcript levels were maximum.
In contrast, Nf-ya, Nf-yb, Nf-yc and Oc2 transcripts dis-
played relatively constant steady state levels, with little
variation during the entire differentiation program. The
relative amounts of Tcf1 and Tcf3, seem to depend on the
differentiation process, with Tcf3  decreasing during dif-
ferentiation [29] and Tcf1  being apparently sensitive to
the culture matrix substrate.
Since mRNA for each transcription factor was present
in ESR1 cells and since no transcription factor could be
discarded on the sole basis of the temporal expression
profile of its transcript, selective mutagenesis experi-
ments were undertaken.
T o  d e t e r m i n e  t h e  r e l a t i v e  i m p o r t a n c e  o f  e a c h  D N A
binding site present in the 79bp-long pdcx-luciferase
fragment, we individually altered each putative binding
site for LEF/TCF, HNF6/OC2 or NF-Y/CAAT in the Dcx
promoter using site-directed mutagenesis to generate
pdcx249bp/Lef*, pdcx249bp/Hnf6* and pdcx249bp/Nf-y*
(Figure 8). Then we compared the luciferase activities
induced by each construct to that of pdcx249bp by tran-
sient expression experiments in ESR1 cells at three stages
of neuronal differentiation. At the beginning of the differ-
entiation program (DD2), mutation of the NF-Y or HNF6
binding sites did not affect pdcx249bp activity (Figure
8a). In contrast, mutation of the LEF/TCF site completely
inhibited  pdcx249bp activity. Such inhibition was not
detected in ESR1 cells at DD8 (Figure 8b). At that stage,
the relative activity of every mutated pdcx249b was below
that of the wild type pdcx249bp but higher than that of
the 79bp-truncated pdcx249bp. Finally, at DD20, when
many ESR1 cells expressed the Dcx gene and displayed a
neuronal phenotype, mutation of any of the four binding
sites reduced the activity of pdcx249bp to that of the
79bp-truncated  pdcx249bp (Figure 8c). Similar results
were found using pdcx1kb (data not shown) and in PND3
cerebellar cells (Figure 8d). Simultaneous mutation of all
three binding sites was also performed (pdcx249bp/Lef*/
Hnf6*/Nf-y*). Transfection experiments revealed that the
transcriptional activation of pdcx249bp mutated for LEF,
HNF6 and NF-Y binding sites is similar to the constructs
with any one mutated site (Additional file 2: Figure S1) at
all stages, suggesting that an additional, not yet identified
factor is responsible for the observed residual activity at
DD8. Altogether, these results demonstrate first of all the
i m p o r t a n c e  o f  L E F / T C F ,  H N F 6 / O C 2  o r  N F - Y / C A A T
DNA binding sites for Dcx promoter activity at various
stages of neuronal differentiation and that the corre-
sponding factors are part of the regulatory mechanisms
controlling Dcx promoter activity. However, these tran-
scription factors are not sufficient to induce full tran-
scriptional activation of the Dcx gene. In addition, the
results obtained with the LEF/TCF binding site reveal
that this binding site could be more specifically involved
in activating pdcx at early stages of neuronal differentia-
tion of ESR1 cells.
Discussion
This present study shows that 249bp-, 1kb-, 2kb-long
DNA fragments located upstream of the Dcx  coding
sequence, are sufficient for in vitro specific Dcx expres-
sion: in heterogeneous differentiated neurons from
mouse embryonic stem (ESR1) cells, in primary mouse
cerebellar neurons (PND3) and in organotypic slice cul-
tures. The regulatory activity of all three constructs, visu-
alized by eGFP expression, overlapped endogenous
expression of Dcx or βIII-Tubulin (data not shown) in
immature neuronal cells. In addition, no eGFP expression
was observed in non-neuronal cells. These results
strongly suggest that the fragments isolated here are suf-
ficient for specific neuronal expression in differentiating
neural cells.
During our analysis of transcriptional activities of the
deletion constructs, we observed a very weak activity of
the 1.2 kb fragment relative to the 1 kb construct, sug-
gesting that the 0.2 kb sequence upstream from pdcx1kb
could contain transcriptional repressor elements. To
determine the regulatory element(s) susceptible to partic-
ipate in transcriptional repression of Dcx expression, we
analyzed this sequence with the MatInspector software
http://www.genomatix.de, but no unique repressor ele-
ment was identified. However, this 0.2 kb sequence holds
a short tandem repeat (STR) of twenty-five CA repeats
(Figure 6), that could act as positive or negative regulator
of gene expression. Short tandem repeats have been iden-
tified and are widespread in coding and non-coding
regions of eukaryotic genomes from yeast to humans
[30,31]. CA repeats are also potential Z-DNA-forming
sequences that could affect gene expression. Indeed,
STRs were shown to activate or repress gene expression
depending on the length of the repeats [32,33]. This
potential repressive element was not further investigated
in this work, but it certainly deserves further attention
also in the context of Dcx-related disease.
Dcx is expressed in differentiating/migrating immature
neurons of embryonic and adult CNS and PNS. More-
over, Dcx presents a maximum expression during cor-
ticogenesis (E14-E18 in mouse) and neurogenesis [18,34].Piens et al. BMC Neuroscience 2010, 11:64
http://www.biomedcentral.com/1471-2202/11/64
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Using a mouse ESC model of neuronal differentiation, we
demonstrated that the transcriptional activity of the Dcx
promoter increased during the differentiation program,
with a maximum activity shortly after the cells were
plated on poly-ornithine/laminin substrates [35]. Both of
these extracellular matrix (ECM) components were
shown to promote the active extension of neuronal cell
protrusions as well as their maturation [36-38]. In the
present study, we further show that ECM components
also promote expression of the endogenous Dcx protein,
in a pattern fully consistent with the transcriptional activ-
ity of the identified promoter region during the same dif-
ferentiation process. This interesting observation
suggests that it is possible to reproduce the Dcx expres-
sion profile in an in vitro cell culture model and use it to
better study the mechanisms involved in neuronal differ-
entiation of ESC [1,2,5,34,39,40].
DNA binding sites for several transcription factors
(E2F, NeuroD1, Brn2,..), known to participate to neuronal
and migration processes were pointed out by bioinfor-
matics analyses of the 2kb-long DNA regulatory
sequence of the mouse Dcx gene. Most of the transcrip-
tion factor binding sites present on the mouse DNA regu-
latory sequence were also detected on a 3.5-kb DNA
fragment upstream of the translation start codon of the
human DCX gene [41]. This human sequence included a
Figure 8 Importance of individual binding site for Dcx promoter activity. (a-b-c) ESR1 cells were transfected with the indicated constructs at day 
of differentiation 0, DD0 (a), DD6 (b) on gelatin and at DD18 (c) on poly-ornithine/laminin and luciferase activity relative to β-galactosidase activity 
was determined 48 hours later. The different constructs were pdcx249bp-Luc, 79bp-deleted pdcx249bp-Luc construct (pdcx249bp--Luc) and 
pdcx249bp-Luc with mutated binding site (pdcx249bp/Lef*, pdcx249bp/Hnf6*, pdcx249bp/Nf-y2* and pdcx249bp/Nf-y3*) and the promoterless con-
trol (CTL). (d) CGN were isolated at post-natal day 3 and were transfected the same day with the indicated constructs and luciferase activity relative 
to β-galactosidase activity was determined 48 hours later. The different constructs were pdcx249bp-Luc, 79bp-deleted pdcx249bp-Luc construct 
(pdcx249bp--Luc) and pdcx249bp-Luc with mutated binding site (pdcx249bp/Lef*, pdcx249bp/Hnf6*, pdcx249bp/Nf-y2* and pdcx249bp/Nf-y3*) and 
the promoterless control (CTL). The activity of each construct is expressed relative to that of the pdcx249bp-Luc construct, set arbitrarily to 1. Note that 
the relative activity of pdcx249bp-Luc, used here as a reference was consistent with the results shown in figure 2. Each value represents the mean ± 
SEM of at least three independent transfection experiments, each performed in triplicate. Asterisks mean significantly different from pdcx249bp values 
at P < 0.05 (*) or P < 0.01 (**).Piens et al. BMC Neuroscience 2010, 11:64
http://www.biomedcentral.com/1471-2202/11/64
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sequence homologous to the sequence used in the pres-
ent study and the first exon of the human DCX gene. Fur-
thermore, deletion experiments revealed the presence of
critical regulatory sequences in a short fragment showing
high sequence homology across species. Within this
sequence, three relevant consensus binding sites were
detected. Each transcription factor selected in the pdcx
3'-end (Lef/Tcf, Hnf6/Oc2, Nf-y/CAAT) is known to play
a role, in a time-dependent manner, in the neuronal dif-
ferentiation program. Mutational analysis revealed the
outstanding importance of the LEF/TCF potential bind-
ing site for activation in early stages of the differentiation
process, while at later stages the activity seems to be
evenly distributed among all the binding sites. Simultane-
ous mutation of all three binding sites located in the 79
bp did not abolish the transcriptional activity of the Dcx
promoter, implying that Dcx residual expression could be
caused by a not yet discovered transcription factor
located in the 79 bp region. Interestingly, the three tran-
scription factors whose expression pattern during neu-
ronal differentiation correlated best with Dcx promoter
activity were Hnf6, Tcf4 and Lef. The latter are mediators
in the canonical Wnt pathway that participates in many
developmental processes in vivo and in vitro [42-46]. The
involvement of Lef in the first steps of Dcx gene activation
is consistent with the observations that some effectors of
the Wnt canonical pathway contribute to neuronal differ-
entiation of pluripotent cells, at least at specific stages
[45,47]. Hirabayashi and co-workers proposed that the
Wnt signaling pathway directs neuronal differentiation in
the developing mouse neocortex [48]. They showed that
activated β-catenin induced differentiation of Neural Pre-
c u r s o r  C e l l s  ( N P C s )  a t  s p e c i f i c  s t a g e s ,  w h e r e a s  o t h e r
studies suggested that Wnt signaling promoted NPC self-
renewal [49]. LEF/TCF and the other identified transcrip-
tion factor complexes also play a role at later stages of the
neuronal differentiation of ESC.
In silico analysis of the Dcx promoter, combined with
mutagenesis experiments and RT-PCR analyses singled
out the interesting ONECUT factors. First, a putative
binding element for HNF6/OC2 was identified (75% con-
served relative to consensus) in the 79 bp sequence (four
on the total sequence of pdcx2kb); second, the Hnf6
mRNA expression profile matched that of Dcx and third,
mutation of the HNF6 binding site abolished Dcx pro-
moter activity. Together, these results suggest that ONE-
CUT factors could be involved in Dcx regulation. Hnf6
and other ONECUT factors have been detected in mouse
[23,24], the zebrafish [50] and also in drosophila and
ascidia developing nervous system [51,52]. All this infor-
mation suggests that HNF6 and other members of the
ONECUT family could play a role during neuronal differ-
entiation and possibly in Dcx regulation. Further experi-
ments are currently underway in order to clarify
ONECUT action on Dcx expression
Data presented in this study suggest that the matura-
tion state of differentiating neuroblasts could be charac-
terized by a specific transcriptional activity of the Dcx
gene. Some data suggest that the mouse embryonic brain
(E14) contains two distinct populations of Dcx-positive
cells, according to their Dcx expression levels [3]. In these
Dcx-positive cells, isolated by flow cytometry from the
b r a i n s  o f  t r a n s g e n i c  m i c e  e x p r e s s i n g  pdcx-eGFP in
embryonic, early postnatal and adult animals, cells with a
low level of Dcx expression (Dcxlow) were multipotent as
shown by their expression of nestin. On the other hand,
Dcxhigh cells showed an established neuronal specifica-
tion, characterized by their expression of neuronal mark-
ers like βIII-Tubulin or MAP2. These results support the
idea that all Dcx+ neuronal precursors do not have the
same potential to differentiate. In this study, neuronal
cells obtained from differentiation of ESC or primary cell
cultures from brain embryos form a heterogeneous neu-
ronal cell population. In this context, it is not surprising
that Dcx+ cells, obtained from ESC differentiation, display
different levels of Dcx promoter activity. This most prob-
ably reflects an asynchrony of differentiating ESC stages
in the same cell culture.
Conclusions
The present work provides a molecular and cellular study
of regulatory sequences (pdcx2kb, pdcx1kb, pdcx249bp),
sufficient to promote specific neuronal expression of
mouse  Dcx  i n  n e u r o b l a s t s .  W e  s h o w  h e r e  t h a t  Dcx
expression is abolished when a specific region in the 3'-
end of the promoter is lacking. In addition transcription
factor binding sites (LEF/TCF, HNF6/OC2 and NF-Y/
CAAT) localized in this promoter region seem to act in a
time-dependent fashion on the transcriptional activity of
the  Dcx  gene during neuronal differentiation of ESC.
Future experiments on these short regulatory sequences
will help to understand the transcriptional regulation of
Dcx gene expression and, maybe to isolate precursors at
defined stages of neuronal differentiation based on their
Dcx expression.
Methods
Animals
All experimental procedures on animals were carried out
according to the European Communities Council Direc-
tive (86/609/EEC) for care and use of Laboratory animals.
The experimental protocols were reviewed and approved
by the institutional Animal Care Committee.
Materials
ES cell culture medium ingredients (DMEM/F12, Neu-
robasal medium, B27 supplement, Bovine Serum Albu-Piens et al. BMC Neuroscience 2010, 11:64
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min and L-glutamine) were obtained from Invitrogen-
Gibco (Merelbeke, Belgium); BMP4 (Bone Morphogenic
Protein-4) was obtained from R&D Systems (Abingdon,
United Kingdom); apo-transferrin, progesterone, insulin,
putrescine, sodium selenite, laminin, poly-ornithine and
all chemicals were obtained from Sigma-Aldrich (St.
Louis, MO, USA) unless specified otherwise and ESGRO®
(LIF, Leukemia Inhibitory Factor) was from Chemicon
International (Temicula, CA, USA) unless specified oth-
erwise.
ESC Culture - Monoculture Differentiation and Transfection
E S R 1  c e l l s  w e r e  m a i n t a i n e d  w i t h o u t  f e e d e r  c e l l s  i n
serum-free culture medium. ESC were plated onto 0.1%
gelatin-coated plates in N2B27 medium (as described by
Ying et al., 2003 [28]) supplemented with ESGRO® (LIF)
103 Units and BMP4 10 ng/ml and incubated at 37°C in
5% CO2. The medium was renewed every day. Cells were
plated every 3 days using a dissociation solution (trypsin
0.05%, chicken serum 1%, EDTA 0.53 mM). To start
monolayer differentiation, corresponding to DD0, undif-
ferentiated cells were dissociated and plated onto 0.1%
gelatin-coated plates at 104cells/cm2 in N2B27 medium
supplemented with ESGRO® (LIF) 103 Units. The medium
(non-supplemented N2B27) was changed every other day
during 8 days, until DD8. Then, at DD8, cells were disso-
ciated and plated on poly-ornithine (100 μg/ml) and
laminin (0.5 μg/ml)-coated plates. The medium was
changed 2 h and 24 h after plating and every 2 days until
20 days of differentiation on porn/lam substrate, corre-
sponding to DD28. ESR1 cells can differentiate into neu-
ral precursors, which could generate functional neurons
[53], astrocytes, and oligodendrocytes [21,22].
Transient transfection experiments were performed
using FuGene-6 (Roche Applied Science, Roche, Man-
nheim, Germany) as described by the manufacturer.
eGFP expression was checked 24 h, 48 h and 72 h after
transfection or luciferase/β-galactosidase activity ratios
were determined 48 hours after transfection. The
luciferase activity was measured according to the
Luciferase Assay System (from Promega, Leiden, The
Netherlands) and is expressed in RLU (Relative Light
Units). The β-galactosidase activity was determined by
reacting 40 μl of lysate with 40 μl of β-galactosidase sub-
strate containing ONPG (o-nitrophenyl-D-galactopyra-
noside) and the absorbance was measured at 420 nm.
Cerebellar Granule Neuron (CGN) Culture and Transfection
Primary cultures of CGNs were obtained from post-natal
day 3 (PND3) 129/sv mice. Isolated cerebella were
stripped off meninges in DPBS (Dulbecco's Phosphate-
Buffered Saline) (Invitrogen-Gibco) supplemented with
glucose (0.45%), minced, and treated with dissociation
solution (0.25% trypsin, 0.01% DNase) for 25 min at 37°C.
Cell dissociation was stopped by adding 0.5 ml of FBS
(Fetal Bovine Serum) to the dissociation solution. Gran-
ule cells were then mechanically dissociated by two suc-
cessive triturations and sedimentation steps in complete
medium (DMEM, 25 mM KCl, 96 mM NaCl, 5 μM insu-
lin, 2 mM glutamine, 1.5% glucose 30%, 1% sodium pyru-
vate, 5% heat-inactivated FBS, 10% horse serum), and
resuspended in 3 ml of complete medium. Neurons were
plated onto poly-ornithine (100 μg/ml)-coated 24-well
culture plates (Nunc, Wiesbaden, Germany) at a density
of ~1 × 104 cells/drop and incubated at 37°C in 5% CO2.
The following day, transient transfection experiments
were performed using FuGene-6 (Roche Applied Science)
as described by the manufacturer. eGFP expression was
checked 24 h, 48 h and 72 h after transfection and the
cells were fixed for immunocytochemistry analysis or
lysed for luciferase/β-galactosidase activity ratio determi-
nation 48 hours after transfection.
Immunocytochemistry (ICC) and Immunohistochemistry 
(IHC)
Glass coverslips were washed in nitric acid (65%) for 1-2
days, rinsed in water for 2-3 hours, then in ethanol 100%
for 2 h, air-dried and sterilized by autoclaving. Cells were
washed in TBS (Tris-Buffered Saline), fixed for 20 min in
4% PFA (paraformaldehyde) at 4°C, washed in TBS and
permeabilized/blocked for minimum 1 h in blocking buf-
fer (TBS, 1% BSA, 0.2% teleostean gelatin, 0.1% Triton-
X100) at room temperature [5]. For Immunohistochemis-
try, the blocking buffer was composed of TBS, 0.25% gela-
tin, 0.1% Triton-X100. The same buffer without Triton
X100 was used for antibody incubations and washes.
Cells were incubated overnight in primary antibody solu-
tion (Table 1) at 4°C (in humid chamber), washed 3 times
and incubated for 1 h in secondary antibody solution at
room temperature (in humid chamber). The latest wash
was performed in TBS before mounting in Vectashield
HardSet Mounting Medium with DAPI (Vector Labora-
tories, Peterborough, United Kingdom).
Western Blotting (WB)
After 2 washes with PBS, cells on 10 cm2 plates were lysed
by adding 300 μl lysis buffer (0.15 M NaCl, 0.05 M Tris-
Base, 1% TritonX-100, 1% Sodium deoxycholate, 0.1%
SDS) supplemented with protease inhibitor cocktail
(Roche) and PMSF (phenylmethylsulfonyl fluoride). After
centrifugation at 4°C, the supernatant was removed and
the protein content was determined using Bradford
reagent (Bio-Rad Laboratories, Hercules, CA, USA).
Samples were boiled in sample buffer (2×: 4% SDS, 10% β-
mercaptoethanol, 135 mM Tris-HCl pH6.8, 20% glycerol,
1% bromophenol blue). Proteins (20 μg/sample) were
separated by 10% SDS-PAGE, and transferred onto PVDF
(Amersham Hybond-P). Blots were blocked in TBST-Piens et al. BMC Neuroscience 2010, 11:64
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BSA 1% and incubated overnight with the primary anti-
body at 4°C. The following day, membranes were washed
and then incubated 1 h with the secondary antibody at
room temperature before washes. Detection was per-
formed using ECL Plus method (Amersham).
Plasmid Construction
The  Mus musculus Doublecortin cDNA sequence is
available under GenBank Accession no. NM010025 and
genomic DNA sequence available under GenBank Acces-
sion no. BX530055, (Sanger Institute, Cambridge United
Kingdom).
Bacterial Colony PCR-based screening was performed
on the Library clone RP23-377E2 Bacterial Artificial
Chromosome (BAC) (Children's Hospital Oakland
Research Institute, California), using the Elongase
Enzyme Mix (Invitrogen-Gibco) and three different 5'-
primers (pdcx forward F1, F1.2, F2) and one 3'-primer
(pdcx reverse):
pdcx F 1: 5'-TTTGTCTCTCTCAGCCTCGG-3'
pdcx F 1.2: 5'-TTCTTAGGTGCTGCTTTCCC-3'
pdcx F 2: 5'-ACTGACCTCTGTTCAGTTCC-3'
pdcx R: 5'-GTTTTCTGCTGGTTGGGTG-3'
Each PCR product (1 kbp, 1.2 kbp, 2 kbp) was cloned
into pGEM-T easy (Promega) and subjected to DNA
sequencing with T7 and SP6 oligonucleotide primers
(GIGA, University of Liège, Belgium). The derived
sequence was confirmed by comparison with the mouse
genomic DNA obtained from C57Bl/6J mice and avail-
a b l e  u n d e r  N C B I  n u c l e o t i d e  b a n k  A c c e s s i o n  n o .
BX530055. Different fragments were cut with Pst1, Hin-
dIII (for pdcx249bp) and Apa1 restriction enzymes (New
England Biolabs, Ipswich, MA, USA) and cloned into the
pEGFP1 vector (BD/Clontech, Heidelberg, Germany).
Integrity of the putative Dcx gene regulatory sequences of
Dcx gene, pdcx-(1 kbp, 1.2 kbp, 2 kbp)-eGFP was con-
firmed by sequencing (Génome Express, Meylan,
France).
(RT)-PCR
Total RNA was extracted from cells (at day 0, 4, 8 on gela-
tin and day 0, 10 and 20 on poly-ornithine/laminin of
ESC differentiation program, corresponding to DD0,
DD4, DD8, DD18 and DD28 respectively) using instapure
solution (Roche Applied Science, Vilvoorde, Belgium).
Total RNA (5 μg) was used for a reverse transcriptional
reaction. PCR was then carried out in a final volume of 50
μl containing 2.5 U of Taq polymerase (Promega), 2 μl of
each selected primer and 0.2 μl of Gapdh primers (10 μM
each, from Eurogentec, Seraing, Belgium), 1 μl of dNTP
mix (10 mM each, from Promega) and 1 μl of the RT
product. The primers used are detailed in Table 2.
PCR products were analyzed on agarose gel (Eurogen-
tec) and quantified using Image Master 1D Prime v3.01
program (Amersham). The results are shown as the rela-
t i v e  a m o u n t  o f  t h e  m R N A  o f  i n t e r e s t  r e l a t i v e  t o  t h e
Gapdh housekeeping gene mRNA.
Site-directed mutagenesis
Site-directed mutagenesis of the LEF, HNF6 and NF-Y
sites in the Dcx promoter was performed on pdcx249bp-
luc plasmid. Whole plasmids carrying the mutation were
obtained by performing PCR using primers listed in Table
3. Amplification reactions were carried out in 50 μl total
volume containing 2.5 U of Pfu polymerase (Promega), 2
μl of each primer (10 μM each; Eurogentec), 1 μl of dNTP
mix (10 mM each; Promega) and 50 ng DNA template
(pdcx249bp-luc) and 2.5 units Pfu Ultra. The thermocy-
cling program used was 94°C for 1 min, followed by 18
cycles of 94°C for 1 min, 55°C for 1 min, 72°C for 10 min
and a final extension cycle of 72°C for 10 min. The tem-
plate was degraded using 10 units of DpnI restriction
endonuclease at 37°C for at least 2 h. After transforma-
Table 1: Antibodies used for immunohistochemistry and Western blot analysis.
Antibody reference Dilution Company
ICC IHC WB
Anti-Dcx(C-18) (Goat) sc-8066 1/200 1/500 1/1000 SantaCruz Biotechnology
Anti-Oct3/4 (C10) (Mouse) sc-5279 1/200 1/200 SantaCruz Biotechnology
Anti-βIII Tubulin (Mouse) T8660 1/1000 Sigma-Aldrich
Anti-α-Tubulin (Mouse) T6074 1/25000 Sigma-Aldrich
Anti-NeuN (Mouse) MAB377 1/100 1/500 Chemicon
TRITC-conjugated (DAG) 705-025-147 1/500 1/500 Jackson Immuno Research
(DAM) 705-205-151 1/500 1/500 Jackson Immuno Research
HRP-conjugate (RAG) A5420 1/2000 Sigma-Aldrich
(MAG) A4416 1/2000 Sigma-AldrichPiens et al. BMC Neuroscience 2010, 11:64
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tion of competent E. coli, recombinant plasmids were iso-
lated and their sequence verified.
Ex vivo electroporation
Plasmids were prepared using the EndoFree Plasmid Kit
(Qiagen, Hilden, Germany). E14.5 pregnant mice were
anesthetized by gas and euthanized by cervical disloca-
tion. The embryonic chain was removed from the
mother, the embryos were isolated from the amniotic sac
and decapitated. DNA was microinjected into lateral ven-
tricles of isolated embryonic mouse heads placed in ice-
cold L-15 medium supplemented with 3% glucose (1 M),
2.6% sodium bicarbonate (1 M) and 1% penicillin/strep-
tomycin (100×). For DNA microinjection (using the Fem-
toJet apparatus, Eppendorf AG, Hamburg, Germany), 75-
mm glass capillary tubes were pulled and tips were bro-
ken. Plasmid solutions were stained with Fast Green solu-
tion (0.05%) to monitor injection sites. Electroporations
were performed on whole heads (skin and skull intact)
using an ECM 830 electroporator (BTX) and the follow-
ing parameters: five 50 ms long pulses separated by 1s
long intervals at 50 V. After pulse delivery, the embryo
heads were immersed in ice-cold L-15 supplemented
with 3% glucose (1 M), 2.6% sodium bicarbonate (1 M)
and 1% penicillin/streptomycin, brains were extracted
and transferred into liquid 3% low melting agarose (37°C;
Bio-Rad Laboratories, Hercules, CA, USA) and incubated
on ice for 1 h. Embedded brains were cut coronally (250
μm) with a vibratome (VT1000S, Leica). Brain slices were
transferred and maintained in organotypic slice cultures
on sterilized culture plate inserts (0.4-μm pore size; Milli-
cell-CM, Millipore Billerica, MA, USA). Brain slices were
maintained in semi-dry conditions in wells containing
Neurobasal medium supplemented with 2% B27, 1% N2,
1% penicillin/streptomycin. After 2 or 3 days, slices were
fixed for 30 min in 4% PFA at 4°C and incubated over-
night in sucrose solution (20%). The following day, slices
were sectioned using a cryostat at 14 micron-thickness
(LEICA CM3050S) and stained for immunofluorescence
as previously described.
Table 2: Primers used for PCR.
Gene Sense primer (3' - 5') Antisense primer (3' - 5') Tm (°C) Ref
Dcx AAGTGACCAACAAGGCTATT TCATTGTGTTTTCTCCCGGA 60 [54]
Lef GAACGAGTCTGAAATCATCC GTAGGGATATCAGGAGCTGG 53 [55]
Tcf1 CATTCCTGGAGTCCTGAAGC CCTGTCAGTTACACCAACG 57 /
Tcf3 AGGAAATCACCAGTCACCGT GTACTTGGCCTGTTCTTCTC 55 [56]
Tcf4 TTCAAAGACGACGGCGAACAG TTGCTGTACGTGATAAGAGGCG 55 [56]
Hnf6 TTCCAGCGCATGTCGGCGCTC GGTACTAGTCCGTGGTTCTTC 55 [57]
Oc2 ATGCCGGTCTCAGGGGACTCTC GGCGAAGAGTGTTCGGCGTTGGAG 55 [58]
Nf-ya CTGGAGCCTCTGATTGGGT CTCTACAGATCCCAGGCAGC 55 [59]
Nf-yb AGGATCCACCACCTTTTTGA TAGCTGGGAGGCATCTGTG 55 [59]
Nf-yc TTTCTTCCATGACTCTGGGC GCTGCTTTCTTCGCTGGA 55 [59]
Gapdh ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA
All sequences were designed using the PRIMER 3 software http://frodo.wi.mit.edu/primer3/input.htm.
Table 3: Primers used for site-directed mutagenesis.
Mutated site Primer (5'- 3') Sequence Ref
pdcxLef* Sense ATCTCTCTATGCCGTGTTTGTCTGAGCTCCAAGC [60]
Antisense GCTTGGAGCTCAGACAAACACGGCATAGAGAGAT
pdcxHnf6* Sense AGGCATAGAGAGCGTTTGTTTCTTTCTCTCAGCATCTCCACCCAACC /
Antisense GGTTGGGTGGAGATGCTGAGAGAAAGAAACAAACGCTCTCTATGCCT
pdcxNf-y1* Sense AGGCATAGAGAGCGGTTTTTTCTTTCTCTCAGCTCTCCACCC [61]
Antisense GGGTGGAGAGCTGAGAGAAAGAAAAAACCGCTCTCTAGCCT
pdcxNf-y2* Sense CGTTGTTTCTGCTGGTTTTGGGTGGAGATGC [61]
Antisense GCATCTCCACCCAAAACCAGCAGAAACAACG
PCR fragments carrying the mutation are obtained by annealing the following primers in the pdcx249bp-Luc plasmid.Piens et al. BMC Neuroscience 2010, 11:64
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Statistical analysis
Statistical analyses were performed by one-way ANOVA
followed by Dunnett's post hoc tests, using a GraphPad
Prism program (GraphPad, San Diego, CA, USA). Each
experiment was performed in triplicates and repeated on
at least three different occasions. Individual comparisons
are expressed as mean ± SD.
Additional material
Abbreviations
Dcx: Doublecortin; CGN: Cerebellar Granule Neurons; DD: Day of Differentia-
tion; BMP4: Bone Morphogenic Protein-4; GFAP: Glial fibrillary acidic protein;
LIF: Leukemia Inhibitory Factor; MAP: Microtubule-Associated Protein; mESC:
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Additional file 1 Putative binding sites found in Dcx regulatory 
sequence of 2 kb. These putative binding sites were detected using Matin-
spector software http://www.genomatix.de.
Additional file 2 Simultaneous mutation of the LEF, HNF6 and NF-Y 
binding sites in Dcx promoter. ESR1 cells were transfected with the indi-
cated constructs at day of differentiation 0 (DD0) and luciferase activity rela-
tive to β-galactosidase activity was determined 48 hours later. The different 
constructs were pdcx249bp-Luc, 79bp-deleted pdcx249bp-Luc construct 
(pdcx249bp--Luc) and pdcx249bp-Luc with mutated binding site 
(pdcx249bp/Lef*, pdcx249bp/Hnf6*, pdcx249bp/Nf-y2*, pdcx249bp/Nf-y3* 
and pdcx249bp/Lef*/Hnf6*/Nf-y2*) and the promoterless control (CTL). The 
activity of each construct is expressed relative to that of the pdcx249bp-Luc 
construct, set arbitrarily to 1. Each value represents the mean ± SD of one 
transfection experiment, performed in triplicate. Asterisks mean signifi-
cantly different from pdcx249bp values at P < 0.05 (*) or P < 0.01 (**).
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